Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Double Bond Pharmaceutical International AB (publ)
AB
Active
Org 5569916082
Virdings Allé 32 B, 754 50
Uppsala
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2014
0 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Double Bond Pharmaceutical International AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
IL
Igor Lokot
Chief Executive Officer
Chief Executive Officer
2020
DP
Dag Peter Zetterling
Audit
Audit
2021
Former (1)
SA
Stéphanie Anna Chantal Ljungberg
Chief Auditor
Chief Auditor
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
SR
Sanna Rejnlander
Chairman
2022
IZ
Irina Zaitseva
Board of Directors
2022
SY
Sergey Yanitsky
Board of Directors
2020
Former (2)
LT
Lars Ture Erik Thomander
Board of Directors
2020 – 2022
PO
Per Olof Knut Stålhandske
Chairman
2020 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Double Bond Pharmaceutical International AB (publ)
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
